STOCK TITAN
  1. Home
  2. Sec-filings
  3. CL
  4. [Form 4] COLGATE PALMOLIVE CO Insider Trading Activity

Colgate-Palmolive (CL) director John Bilbrey receives stock grant and options

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

COLGATE PALMOLIVE CO director John P. Bilbrey reported routine equity compensation and updated holdings. He received a grant of 2,075 shares of Common Stock as an annual director stock grant under the issuer's incentive compensation plan, increasing his direct holdings to 39,820 shares. He also received an annual director stock option grant for 2,424 shares at an exercise price of $86.74 per share, expiring on May 11, 2034, which becomes exercisable in equal annual installments over three years beginning on the first anniversary of the May 11, 2026 grant date. In addition, a separate entry reflects 4,719 shares of Common Stock held indirectly by a trust.

Positive

  • None.

Negative

  • None.
Insider BILBREY JOHN P
Role null
Type Security Shares Price Value
Grant/Award Stock Option (Right to Buy) 2,424 $0.00 --
Grant/Award Common Stock 2,075 $0.00 --
holding Common Stock -- -- --
Holdings After Transaction: Stock Option (Right to Buy) — 2,424 shares (Direct, null); Common Stock — 39,820 shares (Direct, null); Common Stock — 4,719 shares (Indirect, By Trust)
Footnotes (1)
  1. Annual director stock grant under the issuer's incentive compensation plan, credited to a stock unit account pursuant to the issuer's incentive compensation plan. Annual director stock option grant under the issuer's incentive compensation plan. Option becomes exercisable in equal annual installments over three years beginning on the first anniversary of the May 11, 2026 grant date.
Director stock grant 2,075 shares Annual director stock grant of Common Stock
Options granted 2,424 options Annual director stock option grant
Option exercise price $86.74 per share Stock option (Right to Buy) strike price
Option expiration May 11, 2034 Expiration date of stock options
Direct holdings after grant 39,820 shares Common Stock held directly following grant
Indirect trust holdings 4,719 shares Common Stock held indirectly by trust
Annual director stock grant financial
"Annual director stock grant under the issuer's incentive compensation plan"
stock option financial
"Annual director stock option grant under the issuer's incentive compensation plan"
A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.
incentive compensation plan financial
"under the issuer's incentive compensation plan, credited to a stock unit account"
An incentive compensation plan is a formal program that rewards employees and executives with bonuses, stock, or other payments tied to specific performance goals—such as revenue, profit, productivity, or long‑term share price. Investors watch these plans because they shape how leaders make decisions and take risks; like paying a coach by wins rather than effort, well‑designed plans can drive sustainable growth while poor designs can encourage short‑term behaviors that harm shareholder value.
stock unit account financial
"credited to a stock unit account pursuant to the issuer's incentive compensation plan"
exercisable in equal annual installments financial
"Option becomes exercisable in equal annual installments over three years"
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
BILBREY JOHN P
(Last)(First)(Middle)
C/O COLGATE-PALMOLIVE COMPANY
300 PARK AVENUE
(Street)
NEW YORK NEW YORK 10022
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
COLGATE PALMOLIVE CO [ CL ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
05/11/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock05/11/2026A(1)2,075A$0.000039,820D
Common Stock4,719IBy Trust
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Option (Right to Buy)$86.7405/11/2026A(2)2,424 (3)05/11/2034Common Stock2,424$0.00002,424D
Explanation of Responses:
1. Annual director stock grant under the issuer's incentive compensation plan, credited to a stock unit account pursuant to the issuer's incentive compensation plan.
2. Annual director stock option grant under the issuer's incentive compensation plan.
3. Option becomes exercisable in equal annual installments over three years beginning on the first anniversary of the May 11, 2026 grant date.
/s/ Kristine Hutchinson, Attorney-in-Fact05/13/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What did CL director John P. Bilbrey report in this Form 4 filing?

John P. Bilbrey reported routine equity compensation awards. He received 2,075 shares of Common Stock as an annual director stock grant and 2,424 stock options, plus reported 4,719 shares held indirectly by a trust.

How many Colgate-Palmolive (CL) shares did John P. Bilbrey receive as a stock grant?

He received 2,075 shares of Common Stock as an annual director stock grant. The grant was made under Colgate-Palmolive's incentive compensation plan and increased his directly held Common Stock to a reported 39,820 shares.

What are the key terms of John P. Bilbrey’s new Colgate-Palmolive stock options?

He received stock options covering 2,424 shares of Common Stock at an exercise price of $86.74. The options expire on May 11, 2034 and vest in equal annual installments over three years starting on May 11, 2027.

How many Colgate-Palmolive (CL) shares does John P. Bilbrey hold after these transactions?

After the reported grant, he directly holds 39,820 shares of Common Stock. The filing also shows 4,719 additional shares of Common Stock held indirectly by a trust associated with him.

Are John P. Bilbrey’s latest Colgate-Palmolive (CL) transactions open-market buys or sales?

No, the transactions are grants, not open-market trades. The Form 4 shows an annual director stock grant of 2,075 shares and an annual director stock option grant for 2,424 shares under the company’s incentive compensation plan.

How do John P. Bilbrey’s Colgate-Palmolive stock options vest over time?

The options become exercisable in three equal annual installments. Vesting begins on the first anniversary of the May 11, 2026 grant date and continues annually for a total three-year vesting schedule.